Kelix Bio

Acquired

kelixbio.com

Kelix Bio was founded in 2020, is headquartered in Abu Dhabi, United Arab Emirates, lists 51–200 employees, and has $200.0M in recorded funding across 2 rounds.

Headquarters
Abu Dhabi
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$200.0M
Last Round
$200.0M Private EquityJan 2022
Rounds
2
Acquisition Date
Mar 2024

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

KELIX bio is an emerging markets-focused specialty generic biopharmaceutical company providing complex generics and high-complexity products to underserved populations across 40+ countries. Established in November 2020 and now a wholly owned subsidiary of Abu Dhabi sovereign wealth fund Mubadala Investment Company, the company operates a buy-and-build model, having expanded rapidly through acquisitions of manufacturing entities in India, Egypt, Malta, Morocco, and the UAE. KELIX bio competes through innovation and cost leadership in the specialty generics sector, with a focus on sterile liquid and lyophilized pharmaceuticals including antineoplastic products.

Summary

Kelix Bio is a Biotech company based in Abu Dhabi, United Arab Emirates, founded in 2020. It lists 51–200 employees. It has raised $200.0M in total across 2 rounds, most recently a $200.0M Private Equity round in Jan 2022. Investors include Development Partners International, Mubadala Investment Company and British International Investment.

Funding & Exit History

AcquisitionMar 2024

Sign up to see all 3 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kelix Bio on Indexed.vc
<a href="https://indexed.vc/companies/kelix-bio"><img src="https://indexed.vc/api/badge/company/kelix-bio" alt="Kelix Bio on Indexed.vc" width="260" height="76" /></a>